Cerus Corporation Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (29)

Latest Posts

About This Stock More About This Stock
Inovio Rises As CEO Says Zika Vaccine Could Enter Human Testing This Year
Article By: The Fly
Friday, January 29, 2016 8:52 AM EDT
Inovio Pharmaceuticals (INO) shares are rising again this morning as the Zika virus continues to gain attention and its CEO says the company is "ahead of the pack" in developing a vaccine to combat the disease.
In this article: INO, CERS
Read
Cantor Fitzgerald's Caroline Corner: Cutting-Edge Devices And Diagnostics Deliver Drugs And Profits
Article By: The Life Sciences Report
Tuesday, August 4, 2015 11:47 AM EDT
Caroline Corner of Cantor Fitzgerald follows companies with technologies that can both address dire diseases and reap windfalls for investors. Corner brings important names to investors' attention.
In this article: AGN, AEMD, CERS, D-STEM (DEFUNCT), NVIV, AERI, GKOS Also: RHHBY, ALIM, REGN, ONVO, XENT, MRK
Read
Cerus Corporation Jumps Following Clinical Update
Article By: BioMedReports
Monday, January 5, 2015 4:44 PM EDT
Cerus Corporation shares jumped 4% after the company announced that the haemoglobin content (53.1g) of INTERCEPT content treated red blood cell components (RBCs).
In this article: CERS
Read
CERS Reports US Phase 2 Clinical Trial Of INTERCEPT Met Primary Endpoint; VBLT Announces Positive Phase 2a Data For VB-111
Article By: BioMedReports
Tuesday, December 23, 2014 8:18 AM EDT
CERS announced its Phase 2 clinical trial of red blood cells treated with the INTERCEPT Blood System. VBLT announced positive results from its exploratory Phase 2a study of VB-11.
In this article: CERS, VBLT
Read

PARTNER HEADLINES

Latest Tweets for $CERS

No tweets yet!